Nuage Therapeutics Appoints Dr. Stuart Hughes CEO and Vanessa Malier as Chair
Nuage Therapeutics applying its proprietary technology to advance a pipeline of novel agents targeting oncogenic transcription factors.
Nuage Therapeutics applying its proprietary technology to advance a pipeline of novel agents targeting oncogenic transcription factors.